Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Borst

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|October 23, 2021
Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery DiseaseÁlvaro Petersen-Uribe, Marcel Kremser, Anne-Katrin Rohlfing, et al.
International Journal of Cardiology|September 17, 2014
CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failureOliver Borst, Malte Schaub, Britta Walker, et al.
American Journal of Physiology. Cell Physiology|September 19, 2014
Sphingosine kinase 1 (Sphk1) negatively regulates platelet activation and thrombus formationPatrick Münzer, Evi Schmid, Britta Walker, et al.
International Journal of Molecular Sciences|January 11, 2022
Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus FormationJeremy A Nestele, Anne-Katrin Rohlfing, Valerie Dicenta, et al.
Circulation Research|October 1, 2014
Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signalingMadhumita Chatterjee, Oliver Borst, Britta Walker, et al.
The Journal of Biological Chemistry|February 26, 2014
Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor METSebastian Vogel, Madhumita Chatterjee, Katja Metzger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2011
Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusionPeter Seizer, Carmen Ochmann, Tanja Schönberger, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 17, 2015
AMP-activated protein kinase α1 regulates cardiac gap junction protein connexin 43 and electrical remodeling following pressure overloadIoana Alesutan, Jakob Voelkl, Florian Stöckigt, et al.
American Journal of Physiology. Cell Physiology|July 21, 2012
The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in miceTanja Schönberger, Melanie Ziegler, Oliver Borst, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 5, 2012
SGK1 sensitivity of platelet migrationEva-Maria Schmidt, Bjoern F Kraemer, Oliver Borst, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|October 23, 2021
Platelet-Derived PCSK9 Is Associated with LDL Metabolism and Modulates Atherothrombotic Mechanisms in Coronary Artery DiseaseÁlvaro Petersen-Uribe, Marcel Kremser, Anne-Katrin Rohlfing, et al.
International Journal of Cardiology|September 17, 2014
CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failureOliver Borst, Malte Schaub, Britta Walker, et al.
American Journal of Physiology. Cell Physiology|September 19, 2014
Sphingosine kinase 1 (Sphk1) negatively regulates platelet activation and thrombus formationPatrick Münzer, Evi Schmid, Britta Walker, et al.
International Journal of Molecular Sciences|January 11, 2022
Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus FormationJeremy A Nestele, Anne-Katrin Rohlfing, Valerie Dicenta, et al.
Circulation Research|October 1, 2014
Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signalingMadhumita Chatterjee, Oliver Borst, Britta Walker, et al.
The Journal of Biological Chemistry|February 26, 2014
Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor METSebastian Vogel, Madhumita Chatterjee, Katja Metzger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2011
Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusionPeter Seizer, Carmen Ochmann, Tanja Schönberger, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 17, 2015
AMP-activated protein kinase α1 regulates cardiac gap junction protein connexin 43 and electrical remodeling following pressure overloadIoana Alesutan, Jakob Voelkl, Florian Stöckigt, et al.
American Journal of Physiology. Cell Physiology|July 21, 2012
The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in miceTanja Schönberger, Melanie Ziegler, Oliver Borst, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 5, 2012
SGK1 sensitivity of platelet migrationEva-Maria Schmidt, Bjoern F Kraemer, Oliver Borst, et al.
Pageof 14